» Authors » Florence P A M van Hunsel

Florence P A M van Hunsel

Explore the profile of Florence P A M van Hunsel including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 24
Citations 66
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Woerdenbag H, Ursidae M, Ekhart C, Schmidt M, Vitalone A, van Hunsel F
Pharmaceuticals (Basel) . 2024 Nov; 17(11). PMID: 39598401
Products from various parts of species are traditionally applied as a cardiotonic. In Europe and the USA, mainly Jacq. (Lindm.) and (Poir.) DC (synonym L.) are used, but worldwide, other...
2.
Dontje A, Schuiling-Veninga C, van Hunsel F, Ekhart C, Demirci F, Woerdenbag H
Pharmaceuticals (Basel) . 2024 May; 17(5). PMID: 38794141
Conventional therapy is commonly used for the treatment of inflammatory skin conditions, but undesirable effects, such as erythema, dryness, skin thinning, and resistance to treatment, may cause poor patient compliance....
3.
van Rijt-Weetink Y, Egberts T, van Hunsel F, Lewis D, Yates L, Winterfeld U, et al.
Drug Saf . 2024 Jan; 47(3):261-270. PMID: 38183608
Background: To assess the causal relationship between a medicinal product and a reported event, relevant information needs to be present. Information elements for assessing cases of exposure to medicinal products...
4.
Slingerland P, van Hunsel F, Lieber T, van Balveren L, Duijster J
Drug Saf . 2023 Oct; 46(12):1323-1334. PMID: 37882905
Introduction: The annual reformulation of the seasonal influenza vaccine results in fluctuating frequencies and severity of adverse effects following immunization (AEFIs), which stresses the importance of pharmacovigilance. Also, sex-related factors...
5.
Tjeerdsma A, van Hunsel F, van de Koppel S, Ekhart C, Vitalone A, Woerdenbag H
Pharmaceuticals (Basel) . 2023 Aug; 16(8). PMID: 37631050
Phytoestrogens (PEs) are plant-based compounds that can interact with estrogen receptors and are mainly used to treat menopausal complaints. However, the safety of products with assumed phytoestrogenic activity is not...
6.
van der Boom M, van Eekeren R, van Hunsel F
Pharmacoepidemiol Drug Saf . 2023 Mar; 32(7):783-794. PMID: 36919526
Background: The large-scale COVID-19 vaccination campaigns in 2021 and 2022 led to a rapid increase in numbers of received adverse event reports in spontaneous reporting systems. As background incidences of...
7.
Bekhof A, van Hunsel F, van de Koppel S, Woerdenbag H
Phytother Res . 2022 Nov; 37(4):1309-1318. PMID: 36420525
Tea tree (Melaleuca alternifolia) essential oil is widely used as an antiseptic. It mainly consists of monoterpenes with terpinen-4-ol as the major constituent. The aim of this study was to...
8.
Gosselt H, Bazelmans E, Lieber T, van Hunsel F, Harmark L
Pharmacoepidemiol Drug Saf . 2022 Oct; 31(12):1300-1307. PMID: 36251280
Background: The number of Individual Case Safety Reports (ICSRs) in pharmacovigilance databases are rapidly increasing world-wide. The majority of ICSRs at the Netherlands Pharmacovigilance Centre Lareb is reviewed manually to...
9.
Rollema C, Van Roon E, Ekhart C, van Hunsel F, De Vries T
Drugs Real World Outcomes . 2022 Jun; 9(3):321-331. PMID: 35661117
Background: Intranasal corticosteroids are one of the cornerstone treatment options for allergic rhinitis and chronic sinusitis complaints. Safety information in the summary of product characteristics may not be representative for...
10.
van Hunsel F, van der Kooi D, van de Koppel S, Kroes B, Woerdenbag H
Drug Saf . 2022 May; 45(6):651-661. PMID: 35608783
Introduction: The inclusion of herbal medicinal products and herbal supplements in pharmacovigilance systems is important because a systematic approach of collecting and analyzing adverse drug reactions related to these products...